$CBUS
Cibus, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021003104 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $1.943M $7.762M $5.241M
YoY Change -86.05% 48.1% 76.64%
Cost Of Revenue $2.004M $8.281M $7.060M
YoY Change -89.37% 17.29% 100.11%
Gross Profit -$61.00K -$519.0K -$1.819M
YoY Change -98.77% -71.47% 224.24%
Gross Profit Margin -3.14% -6.69% -34.71%
Selling, General & Admin $3.787M $3.859M $4.523M
YoY Change -16.59% -14.68% -27.61%
% of Gross Profit
Research & Development $2.862M $2.579M $2.204M
YoY Change -12.48% 17.01% -38.42%
% of Gross Profit
Depreciation & Amortization $562.0K $596.0K $470.0K
YoY Change 12.4% 26.81% 30.56%
% of Gross Profit
Operating Expenses $6.649M $6.438M $7.231M
YoY Change -14.76% -10.97% -28.63%
Operating Profit -$6.710M -$6.957M -$9.050M
YoY Change -47.33% -23.13% -15.37%
Interest Expense -$347.0K $356.0K $369.0K
YoY Change -15.37% -3.52% -1.34%
% of Operating Profit
Other Income/Expense, Net $6.000K -$102.0K
YoY Change -105.88%
Pretax Income -$7.057M -$7.307M -$9.476M
YoY Change -47.34% -22.89% -11.19%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.057M -$7.307M -$9.476M
YoY Change -47.34% -22.89% -11.18%
Net Earnings / Revenue -363.2% -94.14% -180.81%
Basic Earnings Per Share -$0.20
Diluted Earnings Per Share -$184.3K -$196.0K -$285.5K
COMMON SHARES
Basic Shares Outstanding 38.51M 37.27M
Diluted Shares Outstanding 37.28M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.82M $13.92M $28.00M
YoY Change -52.33% -50.28% -57.83%
Cash & Equivalents $13.82M $13.92M $7.170M
Short-Term Investments $0.00 $0.00 $20.80M
Other Short-Term Assets $1.358M $1.450M $1.900M
YoY Change -68.42% -23.68% 26.67%
Inventory $0.00 $1.674M $5.953M
Prepaid Expenses $859.0K
Receivables $0.00 $206.0K $2.432M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.18M $17.25M $38.30M
YoY Change -61.65% -54.96% -46.56%
LONG-TERM ASSETS
Property, Plant & Equipment $21.73M $21.48M $22.80M
YoY Change -4.94% -5.81% -2.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $183.0K $195.0K $1.400M
YoY Change -34.64% -86.07% 418.52%
Total Long-Term Assets $22.01M $22.27M $24.20M
YoY Change -7.26% -7.98% -2.19%
TOTAL ASSETS
Total Short-Term Assets $15.18M $17.25M $38.30M
Total Long-Term Assets $22.01M $22.27M $24.20M
Total Assets $37.19M $39.52M $62.50M
YoY Change -41.27% -36.77% -35.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.260M $1.037M $1.200M
YoY Change 35.63% -13.58% 26.98%
Accrued Expenses $339.0K $1.139M $5.900M
YoY Change -88.27% -80.69% 201.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $370.0K $387.0K $400.0K
YoY Change -7.5% -3.25% 33.33%
Total Short-Term Liabilities $4.854M $5.100M $7.900M
YoY Change -30.11% -35.44% 36.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $19.50M
YoY Change -100.0% -100.0% 6.56%
Other Long-Term Liabilities $702.0K $971.0K $100.0K
YoY Change 521.24% 871.0% -37.11%
Total Long-Term Liabilities $702.0K $971.0K $19.60M
YoY Change -56.96% -95.05% 12227.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.854M $5.100M $7.900M
Total Long-Term Liabilities $702.0K $971.0K $19.60M
Total Liabilities $23.06M $23.70M $27.60M
YoY Change -12.82% -14.14% 13.67%
SHAREHOLDERS EQUITY
Retained Earnings -$196.1M -$189.0M
YoY Change 17.5%
Common Stock $211.3M $205.9M
YoY Change 3.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.13M $15.83M $34.90M
YoY Change
Total Liabilities & Shareholders Equity $37.19M $39.52M $62.50M
YoY Change -41.27% -36.77% -35.17%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$7.057M -$7.307M -$9.476M
YoY Change -47.34% -22.89% -11.18%
Depreciation, Depletion And Amortization $562.0K $596.0K $470.0K
YoY Change 12.4% 26.81% 30.56%
Cash From Operating Activities -$4.157M -$3.405M -$5.340M
YoY Change -67.19% -36.24% -39.46%
INVESTING ACTIVITIES
Capital Expenditures -$121.0K -$69.00K -$630.0K
YoY Change -81.09% -89.05% -48.36%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $9.140M
YoY Change -100.0% -100.0%
Cash From Investing Activities -$121.0K -$69.00K $8.510M
YoY Change -101.43% -100.81% -797.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.786M -93.00K 120.0K
YoY Change -72.76% -177.5% 140.0%
NET CHANGE
Cash From Operating Activities -4.157M -3.405M -5.340M
Cash From Investing Activities -121.0K -69.00K 8.510M
Cash From Financing Activities 3.786M -93.00K 120.0K
Net Change In Cash -492.0K -3.567M 3.290M
YoY Change -105.07% -208.42% -132.93%
FREE CASH FLOW
Cash From Operating Activities -$4.157M -$3.405M -$5.340M
Capital Expenditures -$121.0K -$69.00K -$630.0K
Free Cash Flow -$4.036M -$3.336M -$4.710M
YoY Change -66.45% -29.17% -38.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001705843
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38161
dei Entity Registrant Name
EntityRegistrantName
Calyxt, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1967997
dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Mount Ridge Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113-1127
dei City Area Code
CityAreaCode
651
dei Local Phone Number
LocalPhoneNumber
683-2807
dei Security12b Title
Security12bTitle
Common Stock (0.0001 par value)
dei Trading Symbol
TradingSymbol
CLXT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38505678
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13922000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17299000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
0
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
11698000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
393000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
393000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4887000
CY2021Q3 us-gaap Inventory Net
InventoryNet
1674000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1383000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1057000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3930000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
17252000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
39590000
CY2021Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
598000
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
597000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21476000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22860000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
195000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
280000
CY2021Q3 us-gaap Assets
Assets
39521000
CY2020Q4 us-gaap Assets
Assets
63327000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1037000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
929000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1139000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2891000
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2284000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1950000
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
149000
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
766000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
387000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
364000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
147000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5143000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6945000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17582000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17876000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1518000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
971000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
113000
CY2021Q3 us-gaap Liabilities
Liabilities
23696000
CY2020Q4 us-gaap Liabilities
Liabilities
26452000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37401876
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37301724
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37165196
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37065044
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
205899000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
204807000
CY2021Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2021Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189035000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166893000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
15825000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39521000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63327000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7762000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5241000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
24044000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9925000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8281000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7060000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26553000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16265000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-519000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-1819000
us-gaap Gross Profit
GrossProfit
-2509000
us-gaap Gross Profit
GrossProfit
-6340000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2579000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2204000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8473000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7816000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3859000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4523000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11595000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15988000
CY2021Q3 clxt Management Fees
ManagementFees
0
CY2020Q3 clxt Management Fees
ManagementFees
68000
clxt Management Fees
ManagementFees
45000
clxt Management Fees
ManagementFees
172000
CY2021Q3 us-gaap Restructuring Costs
RestructuringCosts
0
CY2020Q3 us-gaap Restructuring Costs
RestructuringCosts
436000
us-gaap Restructuring Costs
RestructuringCosts
0
us-gaap Restructuring Costs
RestructuringCosts
436000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6438000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
7231000
us-gaap Operating Expenses
OperatingExpenses
20113000
us-gaap Operating Expenses
OperatingExpenses
24412000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6957000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9050000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22622000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30752000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-356000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-324000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1059000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-568000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-102000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-121000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7307000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9476000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22142000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31441000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7307000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9476000
us-gaap Net Income Loss
NetIncomeLoss
-22142000
us-gaap Net Income Loss
NetIncomeLoss
-31441000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.95
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37279703
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33200289
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37205655
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33076376
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5966488
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5581307
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5966488
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5581307
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
21896000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7307000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1236000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
15825000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
43553000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9476000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
570000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
211000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
38000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
34896000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
us-gaap Net Income Loss
NetIncomeLoss
-22142000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
865000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
227000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
15825000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62508000
us-gaap Net Income Loss
NetIncomeLoss
-31441000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3638000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
211000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-20000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
34896000
us-gaap Profit Loss
ProfitLoss
-22142000
us-gaap Profit Loss
ProfitLoss
-31441000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1776000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1372000
us-gaap Share Based Compensation
ShareBasedCompensation
865000
us-gaap Share Based Compensation
ShareBasedCompensation
3638000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4681000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1310000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-617000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-498000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
291000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3359000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2873000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
108000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
86000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-1742000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
1717000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
334000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-572000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1029000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-183000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14654000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30891000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-11698000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
20802000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
376000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1253000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11322000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22055000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1518000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
271000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
217000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
211000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1512000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3376000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-51434000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14913000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8604000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189000000.0
us-gaap Net Income Loss
NetIncomeLoss
-22100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14700000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14900000
CY2021Q3 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
400000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5100000
CY2020Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
12165000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5613334
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2347663
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.15
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4621173
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
656959
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.70
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
211000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61372
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
602892
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.84
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2685450
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.18
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4613868
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.66
CY2021Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2020Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
211000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
179000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
344000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
179000
CY2021Q3 us-gaap Interest Expense
InterestExpense
356000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4887000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1236000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
570000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
865000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3638000
CY2021Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
10000
CY2020Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
24000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
34000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
71000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
100000
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
199000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4317000
CY2020Q3 us-gaap Interest Expense
InterestExpense
369000
us-gaap Interest Expense
InterestExpense
1075000
us-gaap Interest Expense
InterestExpense
1112000
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
0
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
45000
us-gaap Investment Income Net
InvestmentIncomeNet
16000
us-gaap Investment Income Net
InvestmentIncomeNet
544000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-356000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-324000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1059000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-568000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13922000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17299000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7170000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
393000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
393000
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
393000
CY2021Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
598000
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
597000
CY2020Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1041000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14913000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8604000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
0
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
11698000
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
20802000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
14913000
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
29987000
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
29406000
CY2020Q3 us-gaap Severance Costs1
SeveranceCosts1
400000
CY2020 clxt Severance And Transitional Expenses To Be Paid
SeveranceAndTransitionalExpensesToBePaid
400000

Files In Submission

Name View Source Status
0000950170-21-003104-index-headers.html Edgar Link pending
0000950170-21-003104-index.html Edgar Link pending
0000950170-21-003104.txt Edgar Link pending
0000950170-21-003104-xbrl.zip Edgar Link pending
clxt-20210930.htm Edgar Link pending
clxt-20210930.xsd Edgar Link pending
clxt-20210930_cal.xml Edgar Link unprocessable
clxt-20210930_def.xml Edgar Link unprocessable
clxt-20210930_htm.xml Edgar Link completed
clxt-20210930_lab.xml Edgar Link unprocessable
clxt-20210930_pre.xml Edgar Link unprocessable
clxt-ex10_2.htm Edgar Link pending
clxt-ex31_1.htm Edgar Link pending
clxt-ex31_2.htm Edgar Link pending
clxt-ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img90256459_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending